14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $84.38 $96.99 Tuesday, 23rd Apr 2024 BPMC stock ended at $92.29. This is 1.85% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 6.14% from a day low at $89.19 to a day high of $94.67.
90 days $72.25 $100.98
52 weeks $43.89 $100.98

Historical Blueprint Medicines Corporation prices

Date Open High Low Close Volume
Aug 18, 2020 $75.77 $76.33 $74.89 $75.00 206 631
Aug 17, 2020 $73.95 $75.86 $73.71 $75.58 225 788
Aug 14, 2020 $74.64 $75.42 $73.72 $73.96 226 729
Aug 13, 2020 $74.22 $75.76 $73.52 $75.26 300 936
Aug 12, 2020 $74.01 $75.67 $73.94 $74.18 327 696
Aug 11, 2020 $75.64 $76.68 $74.00 $74.04 317 336
Aug 10, 2020 $75.05 $76.18 $74.23 $75.32 215 518
Aug 07, 2020 $74.28 $76.16 $74.00 $74.45 199 748
Aug 06, 2020 $75.69 $76.06 $73.35 $74.63 328 208
Aug 05, 2020 $74.12 $75.75 $73.85 $75.72 446 316
Aug 04, 2020 $74.79 $75.04 $73.17 $73.56 504 248
Aug 03, 2020 $73.54 $75.92 $72.72 $75.16 380 177
Jul 31, 2020 $74.00 $75.52 $72.65 $73.18 420 280
Jul 30, 2020 $72.30 $74.90 $71.83 $73.89 565 928
Jul 29, 2020 $74.87 $75.41 $73.39 $73.75 340 534
Jul 28, 2020 $75.49 $76.39 $74.14 $74.16 318 185
Jul 27, 2020 $74.92 $77.11 $74.45 $75.76 484 458
Jul 24, 2020 $75.37 $75.97 $73.53 $74.67 377 192
Jul 23, 2020 $77.69 $79.23 $75.15 $76.01 377 034
Jul 22, 2020 $77.02 $79.02 $76.87 $78.45 301 600
Jul 21, 2020 $79.17 $79.19 $76.79 $77.44 465 600
Jul 20, 2020 $78.36 $79.26 $76.57 $78.43 576 000
Jul 17, 2020 $77.50 $78.88 $76.47 $77.67 890 300
Jul 16, 2020 $79.31 $80.00 $76.71 $77.53 946 200
Jul 15, 2020 $81.52 $82.33 $79.55 $80.10 1 000 600
Click to get the best stock tips daily for free!

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT